NEW ENTERPRISE ASSOCIATES
NEW ENTERPRISE ASSOCIATES is a Seed, Series A, Series B and Series C+ fund in the US and Global writing $500K–$50M checks into AI, Fintech, Healthcare and DeepTech.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- AI, Fintech, Healthcare, DeepTech
- Check size
- $500K–$50M
- Invests in
- US-wide, Global
- Round role
- Leads and follows
- Actively investing
- Yes
- Founded
- 1977
- Assets under management
- $35.58B
- Website
- nea.com
Thesis
New Enterprise Associates operates under a massive-scale venture strategy designed to back category-defining technology and life sciences enterprises globally. The fund utilizes a highly resilient dual-practice investment framework that balances high-growth technology sectors with specialized healthcare innovation, allowing it to diversify market cycles. A core differentiator is the fund's extensive scale, which empowers it to write a wide span of check sizes and anchor long-term support from early incubation up to an initial public offering. New Enterprise Associates fundamentally believes that long-term company builder alignment and shared patience matter more than short-term market momentum or personal egos. The firm looks for highly exceptional founders exhibiting immense clarity of thought and the drive to reshape enterprise workflows or clinical outcomes. Instead of reacting critically to structural setbacks, the investment team actively rolls up its sleeves to provide operational mentorship and deep capital reserves to scale a company past industry inflection points.
Common questions
Does NEW ENTERPRISE ASSOCIATES invest at the Seed stage?
Yes. NEW ENTERPRISE ASSOCIATES lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does NEW ENTERPRISE ASSOCIATES write?
NEW ENTERPRISE ASSOCIATES writes $500K–$50M checks.
Where does NEW ENTERPRISE ASSOCIATES invest?
NEW ENTERPRISE ASSOCIATES invests in the US and Global.